HPV Self-Sampling vs Clinician Sampling for Cervical Cancer Screening
The journal club examines a pragmatic randomized controlled trial from Singapore evaluating HPV self-sampling alongside clinician-administered sampling for cervical cancer screening. The study found a 13.8-percentage-point increase in screening uptake when self-sampling was offered, as well as higher high-risk HPV detection, but raises questions about case finding, selection bias, the sequential intervention design, and the use of HPV detection rather than CIN2+ or cervical cancer as the primary endpoint. The discussion considers whether the findings justify national implementation, how to improve equitable uptake among women with lower educational attainment, and what additional evidence—particularly cost-effectiveness, precancer detection, and long-term outcomes—is needed before policy adoption.
BerichtsstilInformativ
Mostly factual and educational, with evidence-based discussion prompts and policy questions rather than strong advocacy.